Tert-butyl 3-[4-[5-(4-cyclohexylphenyl)pyrimidin-2-yl]phenyl]-2-(phenylmethoxycarbonylamino)propanoate
C37H41N3O4 — CID 155084817
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 3-[4-[5-(4-cyclohexylphenyl)pyrimidin-2-yl]phenyl]-2-(phenylmethoxycarbonylamino)propanoate
Tert-butyl 3-[4-[5-(4-cyclohexylphenyl)pyrimidin-2-yl]phenyl]-2-(phenylmethoxycarbonylamino)propanoate (PubChem CID 155084817) has the molecular formula C37H41N3O4 and a molecular weight of 591.75 g/mol. Its IUPAC name is tert-butyl 3-[4-[5-(4-cyclohexylphenyl)pyrimidin-2-yl]phenyl]-2-(phenylmethoxycarbonylamino)propanoate.
Molecular Properties
| Compound Name | Tert-butyl 3-[4-[5-(4-cyclohexylphenyl)pyrimidin-2-yl]phenyl]-2-(phenylmethoxycarbonylamino)propanoate |
|---|---|
| PubChem CID | 155084817 |
| Molecular Formula | C37H41N3O4 |
| Molecular Weight | 591.75 g/mol |
| Exact Mass | 591.31 |
| IUPAC Name | tert-butyl 3-[4-[5-(4-cyclohexylphenyl)pyrimidin-2-yl]phenyl]-2-(phenylmethoxycarbonylamino)propanoate |
| SMILES | CC(C)(C)OC(=O)C(Cc1ccc(-c2ncc(-c3ccc(C4CCCCC4)cc3)cn2)cc1)NC(=O)OCc1ccccc1 |
| InChI | InChI=1S/C37H41N3O4/c1-37(2,3)44-35(41)33(40-36(42)43-25-27-10-6-4-7-11-27)22-26-14-16-31(17-15-26)34-38-23-32(24-39-34)30-20-18-29(19-21-30)28-12-8-5-9-13-28/h4,6-7,10-11,14-21,23-24,28,33H,5,8-9,12-13,22,25H2,1-3H3,(H,40,42) |
| InChIKey | SNYWRALYDSBMGM-UHFFFAOYSA-N |
| XLogP | 8.04 |
| TPSA | 90.41 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 591.75 |
| LogP ≤ 5 | 8.04 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155084817 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.